Bactiquant A/S
CSE:BACTIQ
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3.34
7.95
|
| Price Target |
|
We'll email you a reminder when the closing price reaches DKK.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Bactiquant A/S
Cash & Cash Equivalents
Bactiquant A/S
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Bactiquant A/S
CSE:BACTIQ
|
Cash & Cash Equivalents
kr11.8m
|
CAGR 3-Years
160%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hove A/S
CSE:HOVE
|
Cash & Cash Equivalents
kr13.6m
|
CAGR 3-Years
80%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Aquaporin A/S
CSE:AQP
|
Cash & Cash Equivalents
kr2.8m
|
CAGR 3-Years
22%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hydract A/S
CSE:HYDRCT
|
Cash & Cash Equivalents
kr5.2m
|
CAGR 3-Years
39%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Glunz & Jensen Holding A/S
CSE:GJ
|
Cash & Cash Equivalents
kr1.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
F
|
Fom Technologies A/S
CSE:FOM
|
Cash & Cash Equivalents
kr48m
|
CAGR 3-Years
76%
|
CAGR 5-Years
74%
|
CAGR 10-Years
N/A
|
|
Bactiquant A/S
Glance View
BactiQuant A/S engages in the business to business sale of technology that focuses on handling of water. Bactiquant operates through seven business segments: Aquaculture, Water Utility, Industry, Data Centres, Oil and Gas, Legionella Risk Assessment and Research Institutions. The firm serves customers that come from such industries as public water utility companies, industries needing water cooling or requiring wastewater treatment, as well as aquaculture and operates in five continents.
See Also
What is Bactiquant A/S's Cash & Cash Equivalents?
Cash & Cash Equivalents
11.8m
DKK
Based on the financial report for Dec 31, 2023, Bactiquant A/S's Cash & Cash Equivalents amounts to 11.8m DKK.
What is Bactiquant A/S's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
29%
Over the last year, the Cash & Cash Equivalents growth was 227%. The average annual Cash & Cash Equivalents growth rates for Bactiquant A/S have been 160% over the past three years , 29% over the past five years .
You don't have any saved screeners yet